Literature DB >> 28239890

Successful treatment of refractory palmoplantar pustulosis with apremilast.

G Haebich1, M Kalavala1.   

Abstract

Entities:  

Year:  2017        PMID： 28239890     DOI： 10.1111/ced.13065

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN： 0307-6938            Impact factor:   3.470


× No keyword cloud information.
  3 in total

1.  Off-label studies on apremilast in dermatology: a review.

Authors:  Nolan J Maloney; Jeffrey Zhao; Kyle Tegtmeyer; Ernest Y Lee; Kyle Cheng
Journal:  J Dermatolog Treat       Date:  2019-04-02       Impact factor: 3.359

Review 2.  Palmoplantar Pustulosis: Recent Advances in Etiopathogenesis and Emerging Treatments.

Authors:  Magdalena Misiak-Galazka; Joanna Zozula; Lidia Rudnicka
Journal:  Am J Clin Dermatol       Date:  2020-06       Impact factor: 7.403

3.  [Apremilast in the treatment of palmoplantar pustulosis : A case series].

Authors:  Nina Frischhut; Gudrun Ratzinger
Journal:  Hautarzt       Date:  2021-03       Impact factor: 0.751
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.